Angelini Ventures
Rome, Italy · Seed → Series B
Their stated focus (public profile)
Angelini Ventures is the venture capital firm of Angelini Industries, investing €300 million globally in BioTech and HealthTech companies across Europe and North America. It focuses on leveraging technology to improve healthcare, reshape patient journeys, and address unmet needs in vulnerable populations such as women, children, and the elderly. The firm targets areas including digital health, connected medical devices, life sciences, CNS disorders, mental health, and epilepsy. It invests from Seed through Series B rounds, partnering with founders who combine scientific or clinical expertise with commercial capability.
Stages: Seed → Series B
Sectors: Life sciences, Healthtech, Epilepsy
Check size: €300 million globally
On file: 8 partners on record
Website: angeliniventures.com
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.